HHS, DOD invest to expand U.S. COVID-19 test production

by on

HHS, DOD invest to expand U.S. COVID-19 test production
tjordan_drupal
Nov 2, 2020

The departments of Health and Human Services and Defense this weekend announced a pair of contracts to expand domestic COVID-19 testing capacity. HHS and DOD awarded to Hologic, Inc. $119 million to expand the supplier’s production capacity for COVID-19 tests made at facilities in Wisconsin, Maine and California.

The funds are expected to increase Hologic’s production capacity to 13 million tests per month by January 2022.

The agencies also announced a $12.7 million contract with InBios International, Inc., to expand production of two rapid point-of-care SARS-CoV-2 tests. The funds will enable InBios to reach a production capacity of 400,000 units per week by May 2021.

Headline

HHS, DOD invest to expand U.S. COVID-19 test production
tjordan_drupal
Nov 2, 2020

The departments of Health and Human Services and Defense this weekend announced a pair of contracts to expand domestic COVID-19 testing capacity. HHS and DOD awarded to Hologic, Inc. $119 million to expand the supplier’s production capacity for COVID-19 tests made at facilities in Wisconsin, Maine and California.

The funds are expected to increase Hologic’s production capacity to 13 million tests per month by January 2022.

The agencies also announced a $12.7 million contract with InBios International, Inc., to expand production of two rapid point-of-care SARS-CoV-2 tests. The funds will enable InBios to reach a production capacity of 400,000 units per week by May 2021.

Novel Coronavirus (COVID-19)

Headline

VA:F [1.9.7_1111]
Rating: 0.0/10 (0 votes cast)
VA:F [1.9.7_1111]
Rating: 0 (from 0 votes)

Leave a Comment

Previous post:

Next post: